Overall Status

Terminated (2)

Completed (1)

Sign in for free

Phase

phase 2 (2)

phase 4 (1)

Sponsor

Federal University of Sao Paulo (1)

Merck Sharp & Dohme LLC (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Intervention

mk-3682b (1)

ribavirin (1)

vitamin b 12 (1)

vitamin d (1)

vrc-pbspla043-00-vp (1)

vrc-zkadna090-00-vp (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

Funder Type

Industry (1)

NIH (1)

Other (1)

Study Type

Interventional (3)

flaviviridae infections

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Zika Virus, Zika Virus Infection, Virus Diseases Trial in Worldwide (VRC-ZKADNA090-00-VP, VRC-PBSPLA043-00-VP)

Completed

Has Results

Zika Virus
+6 more

VRC-ZKADNA090-00-VP
VRC-PBSPLA043-00-VP

Miami, Florida
+16 more

Apr 30, 2021

Hepatitis, Hepatitis C, Digestive System Diseases Trial (MK-3682B, Ribavirin)

Terminated

Has Results

Hepatitis
+7 more

(no location specified)

Jul 15, 2019

RNA Virus Infections, Flaviviridae Infections, Hepatitis C Trial in São Paulo (Vitamin D, Vitamin B 12)

Terminated

RNA Virus Infections
+3 more

Vitamin D
Vitamin B 12

São Paulo, Brazil

Outpatient Clinic of Viral Hepatitis (NUPAIG)

Aug 23, 2016